Harm Reduction in an Evolving Drug Landscape

Created using ChatSlide

This presentation delves into the complexities of the illicit drug market, highlighting the proliferation of synthetic opioids and emerging adulterants like fentanyl and xylazine, which contribute to the ongoing overdose crisis. It underscores the need for robust harm reduction strategies, such as drug checking services, syringe programs, and widespread naloxone distribution, to mitigate these risks. Additionally, the discussion addresses the challenges healthcare providers face with...